Browse

Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer

DC Field Value Language
dc.contributor.authorLee, Kyeong-sook-
dc.contributor.authorLee, You-soub-
dc.contributor.authorLee, Jong-min-
dc.contributor.authorIto, Kosei-
dc.contributor.authorCinghu, Senthilkumar-
dc.contributor.authorKim, Jang-hyun-
dc.contributor.authorJang, Ju-won-
dc.contributor.authorLi, Yinghui-
dc.contributor.authorGoh, Yun-mi-
dc.contributor.authorChi, Xin-zi-
dc.contributor.authorWee, Heejun-
dc.contributor.authorLee, Hang Woong-
dc.contributor.authorHosoya, Akihiro-
dc.contributor.authorChung, Jin-haeng-
dc.contributor.authorJang, Ja-june-
dc.contributor.authorKundu, Joydeb Kumar-
dc.contributor.authorSurh, Young-Joon-
dc.contributor.authorKim, Wun-jae-
dc.contributor.authorIto, Yoshiaki-
dc.contributor.authorJung, Han-sung-
dc.contributor.authorBae, Sukchul-
dc.date.accessioned2012-05-31T06:19:36Z-
dc.date.available2012-05-31T06:19:36Z-
dc.date.issued2010-06-
dc.identifier.citationOncogene, Vol.29 No.23, pp.3349-3361-
dc.identifier.issn0950-9232-
dc.identifier.other2594-
dc.identifier.urihttps://hdl.handle.net/10371/76686-
dc.description.abstractHuman lung adenocarcinoma, the most prevalent form of lung cancer, is characterized by many molecular abnormalities. K-ras mutations are associated with the initiation of lung adenocarcinomas, but K-ras-independent mechanisms may also initiate lung tumors. Here, we find that the runt-related transcription factor Runx3 is essential for normal murine lung development and is a tumor suppressor that prevents lung adenocarcinoma. Runx3-/- mice, which die soon after birth, exhibit alveolar hyperplasia. Importantly, Runx3-/- bronchioli exhibit impaired differentiation, as evidenced by the accumulation of epithelial cells containing specific markers for both alveolar (that is SP-B) and bronchiolar (that is CC10) lineages. Runx3-/- epithelial cells also express Bmi1, which supports self-renewal of stem cells. Lung adenomas spontaneously develop in aging Runx3+/- mice (similar to 18 months after birth) and invariably exhibit reduced levels of Runx3. As K-ras mutations are very rare in these adenomas, Runx3+/- mice provide an animal model for lung tumorigenesis that recapitulates the preneoplastic stage of human lung adenocarcinoma development, which is independent of K-Ras mutation. We conclude that Runx3 is essential for lung epithelial cell differentiation, and that downregulation of Runx3 is causally linked to the preneoplastic stage of lung adenocarcinoma. Oncogene (2010) 29, 3349-3361; doi:10.1038/onc.2010.79; published online 15 March 2010-
dc.language.isoenko_KR
dc.publisherNATURE PUBLISHING GROUPko_KR
dc.subjectRUNX3-
dc.subjectlung-
dc.subjectadenocarcinoma-
dc.subjectadenoma-
dc.subjecttumor suppressor-
dc.titleRunx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer-
dc.typeArticle-
dc.contributor.AlternativeAuthor서영준-
dc.identifier.doi10.1038/onc.2010.79-
dc.citation.journaltitleOncogene-
dc.description.citedreferenceChi XZ, 2009, CANCER RES, V69, P8111, DOI 10.1158/0008-5472.CAN-09-1057-
dc.description.citedreferenceIto K, 2009, ONCOGENE, V28, P1379, DOI 10.1038/onc.2008.496-
dc.description.citedreferenceIto T, 2008, ASIAN ECON POLICY R, V3, P237, DOI 10.1111/j.1748-3131.2008.00107.x-
dc.description.citedreferenceDovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105-
dc.description.citedreferencePeacock CD, 2008, J CLIN ONCOL, V26, P2883, DOI 10.1200/JCO.2007.15.2702-
dc.description.citedreferenceLicchesi JDF, 2008, CARCINOGENESIS, V29, P895, DOI 10.1093/carcin/bgn017-
dc.description.citedreferenceCollins LG, 2007, AM FAM PHYSICIAN, V75, P56-
dc.description.citedreferenceWeisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834-
dc.description.citedreferenceLau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369-
dc.description.citedreferenceYano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05-
dc.description.citedreferenceCardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310-
dc.description.citedreferenceWistuba II, 2006, ANNU REV PATHOL-MECH, V1, P331, DOI 10.1146/annurev.pathol.1.110304.100103-
dc.description.citedreferenceSato K, 2006, ONCOL REP, V15, P129-
dc.description.citedreferenceKim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647-
dc.description.citedreferenceIto K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743-
dc.description.citedreferenceChi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005-
dc.description.citedreferenceKim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032-
dc.description.citedreferenceGoel A, 2004, INT J CANCER, V112, P754, DOI 10.1002/ijc.20472-
dc.description.citedreferenceTozawa T, 2004, CANCER SCI, V95, P736-
dc.description.citedreferenceValk-Lingbeek ME, 2004, CELL, V118, P409-
dc.description.citedreferenceTuveson DA, 2004, CANCER CELL, V5, P375-
dc.description.citedreferenceReddy R, 2004, AM J PHYSIOL-LUNG C, V286, pL658, DOI 10.1152/ajplung.00159.2003-
dc.description.citedreferenceLeung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385-
dc.description.citedreferenceFainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085-
dc.description.citedreferenceKang GH, 2004, J PATHOL, V202, P233, DOI 10.1002/path.1503-
dc.description.citedreferenceBishop AE, 2004, CELL PROLIFERAT, V37, P89-
dc.description.citedreferenceXiao WH, 2004, WORLD J GASTROENTERO, V10, P376-
dc.description.citedreferenceLi QL, 2004, BIOCHEM BIOPH RES CO, V314, P223, DOI 10.1016/j.bbrc.2003.12.079-
dc.description.citedreferenceKato N, 2003, AM J PATHOL, V163, P387-
dc.description.citedreferenceWoolf E, 2003, P NATL ACAD SCI USA, V100, P7731-
dc.description.citedreferenceGuo WH, 2002, ONCOGENE, V21, P8351, DOI 10.1038/sj.onc.1206037-
dc.description.citedreferenceTaniuchi I, 2002, MOL CELL, V10, P1083-
dc.description.citedreferenceInoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925-
dc.description.citedreferenceDimri GP, 2002, CANCER RES, V62, P4736-
dc.description.citedreferenceLevanon D, 2002, EMBO J, V21, P3454-
dc.description.citedreferenceLi QL, 2002, CELL, V109, P113-
dc.description.citedreferenceLund AH, 2002, CANCER CELL, V1, P213-
dc.description.citedreferenceMinna JD, 2002, CANCER CELL, V1, P49-
dc.description.citedreferenceJackson EL, 2001, GENE DEV, V15, P3243-
dc.description.citedreferenceBangsow C, 2001, GENE, V279, P221-
dc.description.citedreferenceOsanai M, 2001, ULTRASTRUCT PATHOL, V25, P367-
dc.description.citedreferenceVonlanthen S, 2001, BRIT J CANCER, V84, P1372-
dc.description.citedreferenceBea S, 2001, CANCER RES, V61, P2409-
dc.description.citedreferencePetersen I, 2001, ANAL CELL PATHOL, V22, P111-
dc.description.citedreferenceCOSTA RH, 2001, AM J PHYSIOL-LUNG C, V280, P823-
dc.description.citedreferenceZOCHBAUERMULLER S, 2000, CHEST SURG CLIN N AM, V10, P691-
dc.description.citedreferenceMori M, 1998, ULTRASTRUCT PATHOL, V22, P459-
dc.description.citedreferenceBelinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891-
dc.description.citedreferenceMalkinson AM, 1998, EXP LUNG RES, V24, P541-
dc.description.citedreferenceCazorla M, 1998, MOL CARCINOGEN, V21, P251-
dc.description.citedreferenceLook AT, 1997, SCIENCE, V278, P1059-
dc.description.citedreferenceLee B, 1997, NAT GENET, V16, P307-
dc.description.citedreferenceOtto F, 1997, CELL, V89, P765-
dc.description.citedreferenceMundlos S, 1997, FASEB J, V11, P125-
dc.description.citedreferenceWestra WH, 1996, CANCER RES, V56, P2224-
dc.description.citedreferenceWuenschell CW, 1996, J HISTOCHEM CYTOCHEM, V44, P113-
dc.description.citedreferenceOKUDA T, 1996, MOL DIAGN, V1, P139-
dc.description.tc10-
dc.identifier.scopusid2-s2.0-77953480629-
dc.citation.endpage3361-
dc.citation.number23-
dc.citation.startpage3349-
dc.citation.volume29-
dc.identifier.urlhttps://www.nature.com/articles/onc201079.pdf-
dc.identifier.rimsid2594-
dc.identifier.sci000278622700004-
dc.contributor.affiliatedAuthorSurh, Young-Joon-
Appears in Collections:
Graduate School of Convergence Science and Technology (융합과학기술대학원)Dept. of Molecular and Biopharmaceutical Sciences (분자의학 및 바이오제약학과)Journal Papers (저널논문_분자의학 및 바이오제약학과)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse